Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Shanghai Unicar-therapy Bio-medicine Technology Co.,ltd

Clinical trials sponsored by Shanghai Unicar-therapy Bio-medicine Technology Co.,ltd, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New CAR-T therapy aims to tackle Hard-to-Treat lymphoma Results expected Jan 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Not yet finished but already full! 2

New CAR-T therapy aims to tackle Hard-to-Treat lymphoma

Disease control Recruiting now

This early-stage trial is testing a new treatment called U01 (ssCART-19) for people with B-cell lymphoma that has come back or not responded to standard treatments. The therapy uses a patient's own immune cells, modified to target and kill cancer cells. The study will enroll 30 p…

Phase 1 • Sponsor: Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd • Aim: Disease control

Last updated Jun 27, 2026 12:30 UTC